Reveals long-range allostery in TRMT2A, suggesting new targets for polyQ disease treatment.
TRMT2A has emerged as a disease-modifying target in polyglutamine (PolyQ) models, yet the conformational preferences and allostery of its RNA recognition motif (RRM) remain poorly resolved. Here, we combine extensive atomistic molecular dynamics with Markov state modeling (MSM), transition path theory, and structure-based pocket analysis to map the conformational landscape of the human TRMT2A RRM. We resolve six metastable states and show that a hydrophobic cluster centered on F92-W134-L133 modulates their interconversion. We further identify residues that contribute to RNA strand recognition and reveal state-specific cryptic pockets consistent with the reported binding sites of TRMT2A RRM small-molecule inhibitors. Together, these results support a hinge-gate model in which a soft, defect-enabled α2 segment and a loop 5 hydrophobic cluster coordinate long-range communication between the ribonucleoprotein (RNP) face and the opposite side, yielding testable mutational predictions and state-specific opportunities for allosteric control of TRMT2A in polyQ disease contexts.
No takes yet. Share an insight, caveat, or question.
Khaled et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: